We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Orphan Drug Designation to 4SC´s Oral Pan-HDAC Inhibitor Resminostat for the Treatment of HCC

News   Jul 14, 2011

 
FDA Grants Orphan Drug Designation to 4SC´s Oral Pan-HDAC Inhibitor Resminostat for the Treatment of HCC
 
 
 

RELATED ARTICLES

Fish Oil may Help Fight Against Cancer

News

Omega-3 fatty acids, such as those typically contained in fish oil, may suppress the growth and spread of breast cancer cells in mice.

READ MORE

A Way to Make Drug-like Molecules with Ultra-high Purity

News

Purdue University researchers, including chemistry professor and Nobel Prize winner Ei-ichi Negishi, have developed technology to create a new chemical process to synthesize drug-like molecules with ultra-high purity.

READ MORE

A Bad Influence: The Interplay Between Tumor & Immune Cells

News

Research has yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE